Health Innovation Manchester (HInM) has published its Impact Report for 2022-2023.

The report details how HInM has delivered against all its key commissions from NHS England and the Office of Life Sciences through 2022/23.

Key highlights in the report include:

  • Strong delivery against all national AHSN requirements across its various commissions including delivery to the requirements of NHS England and Office of Life Sciences commissions.
  • Success in the Manchester Biomedical Research Centre bid, which has been awarded £59.1m over five years, a significant uplift on the previous settlement.
  • Successfully securing a grant from Innovate UK and industry investment for a circa £20m innovation accelerator programme.
  • Leading on the design and development of a GM approach for virtual wards, which is now currently delivering >400 virtual beds across the system.
  • Grown the use of GM Care Record by around 25% in year to 19,000 users and 190,000 patient consultations per month, and driven academic outputs from the GM Care Record (3 publications, 42 studies in the pipeline overall).
  • Led the successful wave 1 NHS England Secure Data Environment bid process for GM and the wider NW region, securing £11m over three years.
  • Led on successful bids through 2022/23 to leverage over £100m of investment into the GM system.
  • Meet the innovator: Angie Doshani

    Angie Doshani, is founder of JanamApp and Consultant Obstetrician and Gynaecologist at University Hospitals of Leicester NHS Trust. JanamApp is a ground-breaking solution addressing the disparities in pregnancy outcomes faced by South Asian women, who experience a 1.8 times higher risk compared to their white counterparts. The challenges of some women from this demographic include [...]

  • Polypharmacy Action Learning Set celebrates 1000th delegate

    Lesley Bull, a South London GP and our 1000th delegate chats to Lois-Hooper Ainsworth, Programme Coordinator on the National Polypharmacy Programme, about why she registered for the Health Innovation Network Polypharmacy Action Learning Set, what she got out of it and why other GPs should attend. Lesley Bull So, Lesley, could you tell [...]

  • Meet the innovator: Jo Barosa, Qbtech

    Jo Barosa is Account Director at Qbtech UK. Qbtech is a market leading provider of innovative objective tests for assessing and treating ADHD, changing the landscape of ADHD care. Driven by its mission to improve the lives of people with ADHD, Qbtech supports by providing digital and clinical solutions to improve clinical decision making, service [...]